Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Ocular Pharmacology and Therapeutics, 2025
Inflammatory Proteins Profiling in Tear Fluid in Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration

Chen Y., Zhang S., Zhong Q. et al.

Olink Target 96OphthalmologyPathophysiologyPatient StratificationTear Fluid

Journal of Proteome Research, 2025
A Phosphoproteomic Analysis of Mycobacterial PknG-Mediated Host Immune Evasion

Baros-Steyl S., Nakedi K., Ganief T. et al.

Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant

Neoplasia, 2025
RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells

Kollara A., Madaan V., Zhang J. et al.

Olink Target 96OncologyPatient StratificationFollicular Fluid

Journal of Inflammation Research, 2025
Genetic Association and Drug Target Exploration Between Inflammation-Related Proteins and the Risk of Primary Ovarian Insufficiency

Wang C., Lin X., Yang X.

Olink Target 96GynecologyPathophysiologyPlasma

Aging Cell, 2025
Patterns of Organ‐Specific Proteomic Aging in Relation to Lifestyle, Diseases, and Mortality

Wang Q., Huang J., He Q. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Journal of Affective Disorders, 2025
A novel potential biomarker panel to diagnose depression derived from big proteomic data

Ma S., Tan H., Zhang M. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Critical Care Explorations, 2025
Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda

Conte Cortez Martins G., Lutwama J., Owor N. et al.

Olink Target 96Infectious DiseasesAgingPathophysiologySerum

Circulation: Heart Failure, 2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy

Shah P., Zheng Y., Pieske B. et al.

Olink Target 96CVDPatient StratificationPlasma

Scientific Reports, 2025
Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn’s disease and ulcerative colitis

Prast-Nielsen S., Granström A., Kiasat A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Neurosurgical Review, 2025
Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis

Peng L., Peng H., Wu N. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

British Journal of Cancer, 2025
Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer

Wu W., Huang H., Zhu G. et al.

Olink Target 96OncologyPatient StratificationSerum

Journal of Proteome Research, 2025
Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning

Sun Q., Li S., Ren W. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Allergy, 2025
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses

Zhang Y., Pi J., Wang L. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Open Forum Infectious Diseases, 2025
Two or three? Clinical and proteomic perspectives on dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide as initial HIV treatment

Díaz-García C., Serrano-Villar S., de Morales A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Medicine, 2025
Gut microbiota influences lung cancer risk through circulating cytokines—Insights from a Mendelian randomization study

Shen W., Hou R., Zhang J. et al.

Olink Target 96OncologyPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2025
Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics

Li Y., Zhang S., Lai Y. et al.

Olink Explore 3072/384Metabolic DiseasesEnvironmental Health & ToxicologyPathophysiologySerum

Brain, 2025
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

Karlsson L., Janelidze S., Barthélemy N. et al.

Olink Target 96NeurologyPathophysiologyCSF

BMC Medicine, 2025
Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial

Zhao X., Zhang J., Qiu L. et al.

Olink Target 48OncologyImmunotherapyPatient StratificationSerum

BMC Nephrology, 2025
Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients

Ohlsson M., Nilsson C., Molvin J. et al.

Olink Target 96NephrologyPatient StratificationPlasma

Current Medicinal Chemistry, 2025
Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study

Ji Y., Gao X., Liu L. et al.

Olink Target 96OncologyPathophysiologyPlasma

3360 publications